A Taiwanese infectious disease physician has expressed optimism about a new long-acting injection that, if administered twice a year, could prevent HIV infection in Taiwan.
Yang Chia-jui (楊家瑞), director of the Infection Control Center at Far Eastern Memorial Hospital in New Taipei City, on July 26 said that the long-acting injection had been proven effective during clinical trials in Africa and should also work in Asia.
The outcomes were “exciting,” Yang said, calling the innovative injection very big progress.
Photo courtesy of the Public Health Bureau
He expressed hope that the market release, expected in two years, would become a key tool in Taiwan’s HIV prevention efforts.
The latest results of the long-acting HIV jab’s third-phase clinical trial were announced at the 25th edition of the International AIDS Conference, held from July 22 to 26 in Munich, Germany.
The UN has set a goal to end AIDS by 2030, targeting zero new infections, zero deaths and zero discrimination.
Yang, who was present at the conference, said he hopes the shot would soon be available and that high-risk individuals would be willing to take it as it could help Taiwan achieve its goal of zero HIV infections.
The expert added that the injection provides a certain level of protection and that the side effects are similar to oral medications.
While oral medications have to be taken daily, the injection only needs to be administered every six months, making adherence simpler.
“This [new medication] is a significant advancement,” Yang said, adding that previous trials of oral HIV prevention in Africa failed due to difficulties in maintaining daily medication routines.
The trial in Africa involved 5,300 women, including pregnant and breastfeeding individuals, Yang said.
Trial results compared the efficacy of a long-acting injection (lenacapavir) administered twice a year with daily oral pre-exposure prophylaxis (PrEP).
The results showed that nobody who received the injection became infected with HIV.
Yang said this showed the long-acting jab was more effective at preventing HIV infections than oral medication.
Although women in Africa — in contrast to Asia — have higher infection rates than men, the jab should still to help with prevention efforts in Taiwan, he said.
While currently being used for treatment in Taiwan, the shot still needs approval for preventive use, which might take one to two years, Yang said, adding that trials including men and transgender people are ongoing overseas, with outcomes expected by early next year.
Yang said that over the past five years, Taiwan has seen a noticeable decrease in new HIV cases, primarily due to diagnosis and treatment options that reduce viral loads to undetectable levels.
However, the decreasing trend of new infections is slowing, and Taiwan needs “more effective prevention methods beyond condoms and oral medications,” he said.
The Taiwan Centers for Disease Control has provided oral PrEP for high-risk groups for several years, but adherence challenges limit its effectiveness, he added.
The manufacture of the remaining 28 M1A2T Abrams tanks Taiwan purchased from the US has recently been completed, and they are expected to be delivered within the next one to two months, a source said yesterday. The Ministry of National Defense is arranging cargo ships to transport the tanks to Taiwan as soon as possible, said the source, who is familiar with the matter. The estimated arrival time ranges from late this month to early next month, the source said. The 28 Abrams tanks make up the third and final batch of a total of 108 tanks, valued at about NT$40.5 billion
Two Taiwanese prosecutors were questioned by Chinese security personnel at their hotel during a trip to China’s Henan Province this month, the Mainland Affairs Council (MAC) said yesterday. The officers had personal information on the prosecutors, including “when they were assigned to their posts, their work locations and job titles,” MAC Deputy Minister and spokesman Liang Wen-chieh (梁文傑) said. On top of asking about their agencies and positions, the officers also questioned the prosecutors about the Cross-Strait Joint Crime-Fighting and Judicial Mutual Assistance Agreement, a pact that serves as the framework for Taiwan-China cooperation on combating crime and providing judicial assistance, Liang
A group from the Taiwanese Designers in Australia association yesterday represented Taiwan at the Midsumma Pride March in Melbourne. The march, held in the St. Kilda suburb, is the city’s largest LGBTQIA+ parade and the flagship event of the annual Midsumma Festival. It attracted more than 45,000 spectators who supported the 400 groups and 10,000 marchers that participated this year, the association said. Taiwanese Designers said they organized a team to march for Taiwan this year, joining politicians, government agencies, professionals and community organizations in showing support for LGBTQIA+ people and diverse communities. As the first country in Asia to legalize same-sex
MOTIVES QUESTIONED The PLA considers Xi’s policies toward Taiwan to be driven by personal considerations rather than military assessment, the Epoch Times reports Chinese President Xi Jinping’s (習近平) latest purge of the Chinese People’s Liberation Army (PLA) leadership might have been prompted by the military’s opposition to plans of invading Taiwan, the Epoch Times said. The Chinese military opposes waging war against Taiwan by a large consensus, putting it at odds with Xi’s vision, the Falun Gong-affiliated daily said in a report on Thursday, citing anonymous sources with insight into the PLA’s inner workings. The opposition is not the opinion of a few generals, but a widely shared view among the PLA cadre, the Epoch Times cited them as saying. “Chinese forces know full well that
RSS